V F Tapson

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Room 351 Bell Building, Durham, NC 27710, USA
    Proc Am Thorac Soc 2:71-7. 2005
  2. ncbi request reprint Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism
    Victor F Tapson
    Division of Pulmonary and Critical Care, Box 31175, Room 351 Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Chest 132:936-45. 2007
  3. doi request reprint Interventional therapies for venous thromboembolism: vena caval interruption, surgical embolectomy, and catheter-directed interventions
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Room 351, Bell Building, Box 31175, Duke University Medical Center, Durham, NC, 27710, USA
    Clin Chest Med 31:771-81. 2010
  4. doi request reprint Thrombolytic therapy for acute pulmonary embolism
    Victor F Tapson
    Department of Medicine, Center for Pulmonary Vascular Disease, Duke University Medical Center, Durham, North Carolina 27710, USA
    Semin Thromb Hemost 39:452-8. 2013
  5. doi request reprint Thrombolytic therapy in acute pulmonary embolism
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Center for Pulmonary Vascular Disease, Duke University Medical Center, Durham, North Carolina, USA
    Curr Opin Cardiol 27:585-91. 2012
  6. doi request reprint Acute pulmonary embolism
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    N Engl J Med 358:1037-52. 2008
  7. doi request reprint Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA
    Crit Care Clin 27:825-39, vi. 2011
  8. doi request reprint Deep venous thrombosis and pulmonary thromboembolism: evolving concepts and controversies. Preface
    Victor F Tapson
    Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Semin Respir Crit Care Med 29:1-2. 2008
  9. ncbi request reprint The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy
    Victor F Tapson
    Division of Pulmonary and Critical Care, Box 31175, Room 351, Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Clin Chest Med 24:139-51, vii. 2003
  10. ncbi request reprint Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension
    V F Tapson
    Duke University Medical Center, Durham, NC 27710, USA
    J Vasc Access 7:112-7. 2006

Research Grants

Detail Information

Publications68

  1. ncbi request reprint The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Room 351 Bell Building, Durham, NC 27710, USA
    Proc Am Thorac Soc 2:71-7. 2005
    ..Venous thromboembolism is a frequent and potentially fatal complication of patients with COPD. The interrelationship between smoking, COPD, and coagulation is intriguing and awaits further characterization...
  2. ncbi request reprint Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism
    Victor F Tapson
    Division of Pulmonary and Critical Care, Box 31175, Room 351 Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Chest 132:936-45. 2007
    ..Our aim was to characterize the clinical practices for VTE prophylaxis in acutely ill hospitalized medical patients enrolled in the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)...
  3. doi request reprint Interventional therapies for venous thromboembolism: vena caval interruption, surgical embolectomy, and catheter-directed interventions
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Room 351, Bell Building, Box 31175, Duke University Medical Center, Durham, NC, 27710, USA
    Clin Chest Med 31:771-81. 2010
    ..The indications, contraindications, and available data supporting these therapeutic methods are discussed...
  4. doi request reprint Thrombolytic therapy for acute pulmonary embolism
    Victor F Tapson
    Department of Medicine, Center for Pulmonary Vascular Disease, Duke University Medical Center, Durham, North Carolina 27710, USA
    Semin Thromb Hemost 39:452-8. 2013
    ..Risk stratification in acute pulmonary embolism is important in determining which patients are the most appropriate candidates for thrombolysis, with careful consideration of contraindications...
  5. doi request reprint Thrombolytic therapy in acute pulmonary embolism
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Center for Pulmonary Vascular Disease, Duke University Medical Center, Durham, North Carolina, USA
    Curr Opin Cardiol 27:585-91. 2012
    ..Although an evidence base exists, unanswered questions remain regarding the use of thrombolytic agents...
  6. doi request reprint Acute pulmonary embolism
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    N Engl J Med 358:1037-52. 2008
  7. doi request reprint Treatment of pulmonary embolism: anticoagulation, thrombolytic therapy, and complications of therapy
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC, USA
    Crit Care Clin 27:825-39, vi. 2011
    ..Thus, the morbidity and mortality associated with VTE remain high. The therapeutic approach to acute VTE is discussed in this article, with a particular focus on the intensive care unit setting...
  8. doi request reprint Deep venous thrombosis and pulmonary thromboembolism: evolving concepts and controversies. Preface
    Victor F Tapson
    Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Semin Respir Crit Care Med 29:1-2. 2008
  9. ncbi request reprint The evolution and impact of the American College of Chest Physicians consensus statement on antithrombotic therapy
    Victor F Tapson
    Division of Pulmonary and Critical Care, Box 31175, Room 351, Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Clin Chest Med 24:139-51, vii. 2003
    ..A perspective on the impact of the recommendations is offered...
  10. ncbi request reprint Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension
    V F Tapson
    Duke University Medical Center, Durham, NC 27710, USA
    J Vasc Access 7:112-7. 2006
    ..Treprostinil's anti-platelet aggregation characteristics and stability at room temperature may allow for low infusion rates (0.1-0.2 mL/hr) using a miniaturized infusion pump...
  11. ncbi request reprint Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Proc Am Thorac Soc 3:564-7. 2006
    ..Further prospective epidemiologic studies are needed to better define the incidence and prevalence of CTEPH...
  12. ncbi request reprint Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, Room 351 Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Chest 129:683-8. 2006
    ..With continuous IV treprostinil having potential advantages over both of the above therapies, we investigated the safety and efficacy of this regimen in patients with PAH...
  13. ncbi request reprint Antithrombotic therapy practices in US hospitals in an era of practice guidelines
    Victor F Tapson
    Division of Pulmonary Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Arch Intern Med 165:1458-64. 2005
    ..Antithrombotic therapy is efficacious for the prevention of thromboembolic disease, but it necessitates careful risk-benefit assessment...
  14. ncbi request reprint Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study
    S M Palmer
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Chest 116:127-33. 1999
    ..We hypothesized that rabbit antithymocyte globulin (RATG) induction therapy would decrease acute rejection after lung transplantation, and we designed a single-center, randomized, prospective study to test this hypothesis...
  15. ncbi request reprint Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation
    S M Palmer
    Department of Medicine, Duke University Medical Center, Durham NC, USA
    Chest 118:1214-7. 2000
    ..We suggest that GER should be considered among the potential causes of allograft dysfunction after lung transplantation...
  16. ncbi request reprint Lung transplantation after long-term mechanical ventilation : results and 1-year follow-up
    M A Baz
    Department of Medicine, University of Florida, Gainesville, FL 32610, USA
    Chest 119:224-7. 2001
    ..We report on the results of transplantation in nine patients requiring long-term mechanical ventilation at two lung transplant centers...
  17. ncbi request reprint Prophylaxis strategies for patients with acute venous thromboembolism
    V F Tapson
    Division of Pulmonary and Critical Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Am J Manag Care 7:S524-31; discussion S531-4. 2001
    ..It is now being recommended that hospitals develop formal strategies that address the prevention of thromboembolic complications and that general medical patients at risk of VTE receive unfractionated heparin or LMWH...
  18. ncbi request reprint Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection
    S M Palmer
    Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Transplantation 71:1772-6. 2001
    ..CONCLUSIONS: Acute rejection rates and overall survival at 6 months are similar in lung transplant recipients treated with either MMF- or AZA-based immunosuppression...
  19. ncbi request reprint Venous thromboembolism in intensive care patients
    Ana T Rocha
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Box 3221, Durham, NC 27710, USA
    Clin Chest Med 24:103-22. 2003
    ..Further investigation of diagnostic strategies that include adequate consideration of clinical diagnosis using standardized models and noninvasive imaging are warranted...
  20. ncbi request reprint Acute pulmonary embolism
    Victor F Tapson
    Division of Pulmonary and Critical Care Medicine, 353 Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Cardiol Clin 22:353-65, v. 2004
    ..Furthermore, prophylaxis continues to be dramatically underused. The incidence of venous thromboembolism is high in hospitalized patients, and both surgical as well as medical patients are at risk...
  21. ncbi request reprint Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy
    Sarah A Myers
    Division of Dermatology, Department of Medicine, Duke University Medical Center, Durham, NC 27705, USA
    J Am Acad Dermatol 51:98-102. 2004
    ..This report describes the cutaneous and dermatopathologic findings of 12 patients who developed persistent rash while receiving long-term prostacyclin for PAH...
  22. ncbi request reprint Massive pulmonary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case report and review of treatment options
    Gregory S Ahearn
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Box 31175, Durham, NC 27710, USA
    Arch Intern Med 162:1221-7. 2002
  23. doi request reprint Prevention of venous thromboembolism in medical patients and outpatients
    Gregg J Stashenko
    Division of Pulmonary and Critical Care, Duke University Medical Center, Box 31175, Room 351 Bell Building, Durham, NC 27710, USA
    Nat Rev Cardiol 6:356-63. 2009
    ..In this Review, we examine the literature on VTE prophylaxis in hospitalized medical patients, and evaluate the available data for the outpatient setting...
  24. doi request reprint D-dimers and efficacy of clinical risk estimation algorithms: sensitivity in evaluation of acute pulmonary embolism
    Rajan T Gupta
    Department of Radiology, Duke University Medical Center, DUMC Box 3808, Durham, NC 27710, USA
    AJR Am J Roentgenol 193:425-30. 2009
    ..The goal of this study was to test the efficacy of clinical risk algorithms and a quantitative immunoturbidimetric D-dimer assay in the evaluation of patients undergoing pulmonary CT angiography for suspected acute pulmonary embolism...
  25. ncbi request reprint Clinical practice. The evaluation of suspected pulmonary embolism
    Peter F Fedullo
    Division of Pulmonary and Critical Care Medicine, University of California, San Diego, Medical Center, San Diego, La Jolla, CA 92037 1300, USA
    N Engl J Med 349:1247-56. 2003
  26. doi request reprint Clinical probability and D-dimer testing: how should we use them in clinical practice?
    C William Hargett
    Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Semin Respir Crit Care Med 29:15-24. 2008
    ..The evidence for this strategy is strongest in younger outpatients with no associated comorbidities, no prior history of VTE, and a short duration of symptoms...
  27. ncbi request reprint Thrombosis during pregnancy and the postpartum period
    Andra H James
    Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710 and Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Obstet Gynecol 193:216-9. 2005
    ..To describe the circumstances surrounding deep vein thrombosis among pregnant or postpartum patients enrolled in a large multicenter registry...
  28. doi request reprint Thrombolytic therapy for acute pulmonary embolism: a critical appraisal
    Jamie L Todd
    Division of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Chest 135:1321-9. 2009
    ..We also discuss risk stratification techniques and propose a clinical algorithm for the incorporation of thrombolytic therapy...
  29. ncbi request reprint Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
    R N Channick
    Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA, USA
    Lancet 358:1119-23. 2001
    ..We describe the efficacy and safety of bosentan, a dual endothelin-receptor antagonist that can be taken orally, in patients with severe pulmonary hypertension...
  30. ncbi request reprint Infectious complications of lung transplantation
    B D Alexander
    Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Transpl Infect Dis 3:128-37. 2001
    ..The epidemiology, prophylaxis, and treatment of infections following lung transplantation are critical areas for continued research...
  31. ncbi request reprint Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation
    D Hadjiliadis
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Heart Lung Transplant 20:1305-9. 2001
    ..0001). CONCLUSIONS: CEA levels are high in patients with end-stage lung disease, especially IPF. Their levels appear to be a marker of the underlying disease and do not predict the post-transplant survival or development of malignancy...
  32. ncbi request reprint Severe erythroderma as a complication of continuous epoprostenol therapy
    Gregory S Ahearn
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Chest 122:378-80. 2002
    ..The patient' condition improved after rapid tapering of her epoprostenol and administration of corticosteroids. Epoprostenol may be associated rarely with severe erythroderma...
  33. doi request reprint Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy
    Gustavo B F Oliveira
    Duke Clinical Research Institute, Duke University Medical Center, 2400 Pratt St, Durham, NC 27705, USA
    Arch Intern Med 168:94-102. 2008
    ..Despite widespread heparin use in clinical practice, the associated development of thrombocytopenia is an underrecognized and undertreated complication...
  34. ncbi request reprint Safety of aerosolized amphotericin B lipid complex in lung transplant recipients
    S M Palmer
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 22710, USA
    Transplantation 72:545-8. 2001
    ..Additional prospective, randomized studies are needed to determine the efficacy of aerosolized ABLC alone or in conjunction with systemic therapies in the prevention of fungal infections in lung transplant recipients...
  35. ncbi request reprint Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension
    C William Hargett
    Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Semin Respir Crit Care Med 26:385-93. 2005
    ..Because plasma BNP levels rise in a variety of cardiopulmonary conditions and are affected by several physiological factors, BNP interpretation must not occur in isolation but rather within the context of good clinical judgment...
  36. ncbi request reprint Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease
    Gregory S Ahearn
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
    Chest 122:524-7. 2002
    ..To determine the utility of the ECG for predicting clinical status in adults with primary pulmonary hypertension (PPH) or pulmonary arterial hypertension (PAH) secondary to collagen vascular disease...
  37. pmc A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension
    Timothy J McMahon
    Department of Medicine and Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
    Proc Natl Acad Sci U S A 102:14801-6. 2005
    ..Chemical restoration of SNO-Hb levels in both animals and patients restores the vasodilator activity of RBCs, and this activity is associated with improved oxygenation and lower PAPs...
  38. doi request reprint Thrombolytic therapy for venous thromboembolism: current clinical practice
    Gregg J Stashenko
    Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Hosp Med 4:313-6. 2009
    ....
  39. ncbi request reprint Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopen
    E Magnus Ohman
    Division of Cardiology, Division of Hematology, and School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599 7075, USA
    J Thromb Thrombolysis 19:11-9. 2005
    ..Both HIT and HITT are associated with high morbidity and mortality and represent substantial worldwide public health concerns...
  40. pmc Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II
    Paul D Stein
    Department of Research, St Joseph Mercy Oakland Hospital, Pontiac, Mich 48341 5023, USA
    Am J Med 120:871-9. 2007
    ....
  41. ncbi request reprint Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension
    Mardi Gomberg-Maitland
    Section of Cardiology, Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    J Heart Lung Transplant 26:732-8. 2007
    ..We compared the Naughton-Balke treadmill test reported in exercise metabolic equivalents (METs) with the 6MWT to evaluate whether MET could be a useful tool to assess exercise capacity...
  42. pmc Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
    Reda E Girgis
    Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA
    Ann Rheum Dis 66:1467-72. 2007
    ..Short-term clinical and haemodynamic effects and longer-term follow-up data are presented...
  43. ncbi request reprint A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis
    Samuel Z Goldhaber
    The Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Am J Cardiol 93:259-62. 2004
    ..Of the 2,726 patients who had their DVT diagnosed while in the hospital, only 1,147 (42%) received prophylaxis within 30 days before diagnosis...
  44. ncbi request reprint Sitaxsentan therapy for pulmonary arterial hypertension
    Robyn J Barst
    Columbia University College of Physicians and Surgeons, 3959 Broadway, BHN 2 255, New York, NY 10032 1551, USA
    Am J Respir Crit Care Med 169:441-7. 2004
    ..02 for each parameter at both doses). The incidence of elevated aminotransferase values (> three times normal) was 3% for the placebo group, 0% for the 100-mg group, and 10% for the 300-mg group...
  45. ncbi request reprint Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study
    Olivier Sitbon
    Service de Pneumologie RĂ©animation Respiratoire, Hopital Antoine Beclere, 157, Avenue de la Porte Trivaux, F 92141 Clamart Cedex, France
    Chest 124:247-54. 2003
    ..We report on the long-term safety and efficacy of bosentan treatment in patients with pulmonary arterial hypertension (PAH)...
  46. ncbi request reprint The diagnosis of acute venous thromboembolism
    Victor F Tapson
    Dis Mon 51:86-93. 2005
  47. ncbi request reprint Diagnosing and managing acute pulmonary embolism: role of cardiac troponins
    Victor F Tapson
    Am Heart J 145:751-3. 2003
  48. ncbi request reprint Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension
    Vallerie V McLaughlin
    Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    J Cardiovasc Pharmacol 41:293-9. 2003
    ..Subcutaneous treprostinil has favorable hemodynamic effects when given acutely and in the short term. Treprostinil can be given safely to an ambulatory patient with a novel subcutaneous delivery pump system...
  49. ncbi request reprint Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial
    Gerald Simonneau
    Service de Pneumologie, Hopital Antoine Beclere, Universite Paris Sud, Clamart, France
    Ann Intern Med 149:521-30. 2008
    ..Oral sildenafil and intravenous epoprostenol have independently been shown to be effective in patients with pulmonary arterial hypertension...
  50. ncbi request reprint Chronic thromboembolic pulmonary hypertension
    Franco Piovella
    IRCCS Policlinico San Matteo, Pavia, Italy
    Semin Thromb Hemost 32:848-55. 2006
    ..At the 3-year follow-up, 94% of patients were in NYHA class I or II and were being treated with oral anticoagulants only...
  51. ncbi request reprint Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
    Alexander T Cohen
    Vascular Medicine, Department of Surgery, Guy s, King s and St Thomas School of Medicine, London, UK
    Thromb Haemost 94:750-9. 2005
    ..These medical conditions and risk factors are included in a risk-assessment model which is hoped will provide a simple means of assisting clinicians in deciding whether thromboprophylaxis should be used in an individual patient...
  52. ncbi request reprint Few predictors of massive deep vein thrombosis
    Hylton V Joffe
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Thromb Haemost 94:986-90. 2005
    ..02-1.34) was the only independent predictor of massive DVT. Thrombus propagation from the femoropopliteal system cannot be reliably predicted using demographic or clinical characteristics...
  53. ncbi request reprint Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs
    Joseph A Caprini
    Evanston Northwestern Healthcare and Feinberg School of Medicine, Northwestern University, Chicago, Ill, USA
    J Vasc Surg 42:726-33. 2005
    ..To assess the treatment of venous thromboembolism (VTE) in hospitalized patients enrolled in a national, multicenter database...
  54. ncbi request reprint Multidetector computed tomography for acute pulmonary embolism
    Paul D Stein
    Department of Research, St Joseph Mercy Oakland Hospital, Pontiac, Mich, USA
    N Engl J Med 354:2317-27. 2006
    ..The accuracy of multidetector computed tomographic angiography (CTA) for the diagnosis of acute pulmonary embolism has not been determined conclusively...
  55. ncbi request reprint Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study
    Russell D Hull
    Thrombosis Research Unit, Foothills Hospital, University of Calgary, Room 601 South Tower, 1403 29th Street NW, Calgary, T2N 2T9, Alberta, Canada
    J Thromb Thrombolysis 22:31-8. 2006
    ....
  56. ncbi request reprint Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation
    Albert L Waldo
    Division of Cardiology, Case Western University University Hospitals of Cleveland, Cleveland, Ohio 44106 5038, USA
    J Am Coll Cardiol 46:1729-36. 2005
    ..The purpose of this study was to determine both treatment gaps and predictors of warfarin use in atrial fibrillation (AF) patients enrolled in a national multicenter study...
  57. ncbi request reprint High utilization rate of vena cava filters in deep vein thrombosis
    Michael R Jaff
    Massachusetts General Hospital, 55 Fruit Street, Yawkey Center for Outpatient Care, Room 5938, Boston, Massachusetts 02114, USA
    Thromb Haemost 93:1117-9. 2005
    ..Many of these patients may have warranted less invasive methods of venous thromboembolism prophylaxis. Improved physician education regarding mechanical and pharmacologic prophylaxis alternatives might reduce the use of IVCFs...
  58. ncbi request reprint Gender differences in the administration of prophylaxis to prevent deep venous thrombosis
    Nils Kucher
    Department of Medicine, Brigham and Women s Hospital, 75 Francis Street, Boston, Massachusetts, 02115 USA
    Thromb Haemost 93:284-8. 2005
    ..Men were 21% more likely than women to receive prophylaxis (OR 1.21, 95% CI 1.03-1.43; p=0.021) after adjusting for DVT risk factors, including surgery, trauma, prior DVT, age, and cancer...
  59. ncbi request reprint Upper-extremity deep vein thrombosis: a prospective registry of 592 patients
    Hylton V Joffe
    Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Circulation 110:1605-11. 2004
    ..Upper-extremity deep vein thrombosis (UEDVT) occurs spontaneously or sometimes develops as a complication of pacemaker use, long-term use of a central venous catheter (CVC), or cancer...
  60. ncbi request reprint Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
    Mardi Gomberg-Maitland
    Pulmonary Hypertension Center, University of Chicago Hospitals, 5841 South Maryland Avenue, MC 2016, Chicago, IL 60637, USA
    Am J Respir Crit Care Med 172:1586-9. 2005
    ..With the demonstration of bioequivalence between subcutaneous and intravenous treprostinil, intravenous treprostinil may have an overall better risk-benefit profile than intravenous epoprostenol...
  61. ncbi request reprint Protect your health in the air. Most people with chronic health conditions can travel by air safely--if they take a few precautions
    Victor F Tapson
    Health News 8:3, 11. 2002
  62. ncbi request reprint The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use
    Richard A Krasuski
    Division of Cardiology, Wilford Hall Medical Center, Lackland AFB, TX 78236 5300, USA
    Am Heart J 150:725-8. 2005
    ..Many patients, however, are already on vasodilators at the time of testing. It is unclear if these agents should be temporarily discontinued to improve the sensitivity of testing...
  63. ncbi request reprint Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel
    Suresh Vedantham
    Mallinckrodt Institute of Radiology, Department of Radiology, Washington University of School of Medicine, St Louis, Missouri 63110, USA
    J Vasc Interv Radiol 16:1567-73. 2005
  64. doi request reprint Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
    Alexander T Cohen
    King s College Hospital, London, UK
    Lancet 371:387-94. 2008
    ....
  65. ncbi request reprint Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
    Vallerie V McLaughlin
    The University of Michigan Health System, Ann Arbor, Michigan, USA
    Am J Respir Crit Care Med 174:1257-63. 2006
    ..Small, open-label studies suggest that combinations of existing therapies may be effective for pulmonary arterial hypertension (PAH)...
  66. ncbi request reprint End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives
    Marius M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
    J Am Coll Cardiol 43:48S-55S. 2004
    ..Finally, cardiopulmonary exercise testing, echocardiographic studies, and biochemical parameters, such as brain natriuretic peptide or troponin T, may also prove useful as secondary end points in the future...
  67. ncbi request reprint Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators
    Paul D Stein
    Department of Research, St Joseph Mercy Oakland Hospital, Pontiac, Mich 48341 5023, USA
    Am J Med 119:1048-55. 2006
    ..To formulate comprehensive recommendations for the diagnostic approach to patients with suspected pulmonary embolism, based on randomized trials...
  68. ncbi request reprint Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators
    Paul D Stein
    Department of Research, St Joseph Mercy Oakland Hospital, 44405 Woodward Ave, Pontiac, MI 48341 5023, and Department of Medicine, Wayne State University, Detroit, MI, USA
    Radiology 242:15-21. 2007

Research Grants1

  1. PROSPECTIVE INVESTIGATION OF PULMONARY EMBOLISM DX-II
    Victor Tapson; Fiscal Year: 2003
    ..abstract_text> ..